Our meta-analysis showed that exercise intervention significantly reduced IGF-1 levels in breast cancer survivors, and further subgroup analyses showed significant improvements in IL-6 levels in the exercise group compared with the control group when the intervention period was longer than 12 weeks and a significant effect of exercise on CRP and IL-10 levels when the intervention period was less than or equal to 12 weeks. This evidence concerns the gene CRP and breast carcinoma.